(Q35883911)

10 August 2017

1 reference

title

Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern (English)

1 reference

10 August 2017

0 references

Streptococcus pneumoniae

1 reference

1

Thomas M File

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

American Journal of Medicine

10 August 2017

published in

1 reference

10 August 2017

volume

117 Suppl 3A

1 reference

10 August 2017

page(s)

39S-50S

1 reference

Pneumonia caused by penicillin-non-susceptible and penicillin-susceptible pneumococci in adults: a case-control study.

10 August 2017

cites work

1 reference

12 December 2020

Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990).

1 reference

12 December 2020

Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin

1 reference

12 December 2020

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

1 reference

12 December 2020

Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia

1 reference

12 December 2020

Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia

1 reference

12 December 2020

Macrolide resistance among invasive Streptococcus pneumoniae isolates

1 reference

12 December 2020

Antimicrobial Resistance in Streptococcus pneumoniae: An Overview

1 reference

12 December 2020

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

1 reference

12 December 2020

Pneumonic vs nonpneumonic acute exacerbations of COPD.

1 reference

12 December 2020

Community-acquired pneumonia

1 reference

12 December 2020

Fluoroquinolone resistance in Streptococcus pneumoniae

1 reference

12 December 2020

A prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

12 December 2020

Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance

1 reference

12 December 2020

Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina

1 reference

12 December 2020

The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents

1 reference

12 December 2020

Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.

1 reference

12 December 2020

Emergence of macrolide resistance during treatment of pneumococcal pneumonia

1 reference

12 December 2020

COPD exacerbations: to X-ray or not to X-ray.

1 reference

12 December 2020

The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000.

1 reference

12 December 2020

Economic burden of pneumonia in an employed population.

1 reference

12 December 2020

The cost of treating community-acquired pneumonia.

1 reference

12 December 2020

Community-acquired pneumonia. A prospective outpatient study

1 reference

12 December 2020

Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin

1 reference

12 December 2020

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

1 reference

12 December 2020

The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults

1 reference

12 December 2020

Rational use of antibiotics to treat respiratory tract infections

1 reference

12 December 2020

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia

1 reference

12 December 2020

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

1 reference

12 December 2020

Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia

1 reference

12 December 2020

Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group

1 reference

12 December 2020

Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

1 reference

12 December 2020

Pneumococcal Antimicrobial Resistance: The Problem in Hungary

1 reference

12 December 2020

Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study

1 reference

12 December 2020

Epidemiological Features of and Risk Factors for Infection by Streptococcus pneumoniae Strains with Diminished Susceptibility to Penicillin: Findings of a French Survey

1 reference

12 December 2020

Introduction to Table V. Premature deaths, monthly mortality, and monthly physician contacts--United States

1 reference

12 December 2020

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

1 reference

12 December 2020

Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group

1 reference

12 December 2020

Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997

1 reference

12 December 2020

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

1 reference

12 December 2020

Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study

1 reference

12 December 2020

Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study

1 reference

12 December 2020

Drug-resistant Streptococcus pneumoniae.

1 reference

12 December 2020

Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence

1 reference

12 December 2020

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

1 reference

12 December 2020

Antimicrobial resistance in Streptococcus pneumoniae: a South African perspective

1 reference

12 December 2020

Levofloxacin failure in a patient with pneumococcal pneumonia

1 reference

12 December 2020

Levofloxacin treatment failure in a patient with fluoroquinolone-resistant Streptococcus pneumoniae pneumonia

1 reference

12 December 2020

Nonsevere community-acquired pneumonia: correlation between cause and severity or comorbidity

1 reference

12 December 2020

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998

1 reference

12 December 2020

Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy.

1 reference

12 December 2020

Community-acquired pneumonia

1 reference

12 December 2020

An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome

1 reference

12 December 2020

Appropriate use of antimicrobials for drug-resistant pneumonia: focus on the significance of beta-lactam-resistant Streptococcus pneumoniae

1 reference

12 December 2020

Streptococcus pneumoniaeBacteremia: Duration of Previous Antibiotic Use and Association with Penicillin Resistance

1 reference

12 December 2020

Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanate

1 reference

12 December 2020

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

1 reference

12 December 2020

The clinical pharmacokinetics of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate

1 reference

12 December 2020

A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe

1 reference

12 December 2020

Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group

1 reference

12 December 2020

Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s.

1 reference

12 December 2020

Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong

1 reference

12 December 2020

10.1016/J.AMJMED.2004.07.007

Identifiers

DOI

0 references

1 reference